Dr. Sai Vivek V
Consultant - Medical Oncology and Haemato - Oncology
Dr. Sai Vivek is an experienced oncologist currently working as Consultant Medical and Hemato Oncologist at Aster Hospitals, Bangalore. With close to 6 years of experience in the field of oncology, Dr .Vivek has a keen interest in solid organ and blood cancers in adults and children, precision oncology immunotherapy, preventive oncology and integrative oncology. He completed his MBBS in surgery from Sri Devaraj Urs Medical College, Bangalore (2012) and MD in internal medicine from JSS Medical College, Mysore, Karnataka (2015). He also holds a fellowship in medical oncology (DM) from Vydehi institute of Medical sciences, Bangalore (2019) along with a certification in ECMO. Prior to joining Aster Hospitals, Dr. Vivek was working as a consultant at Sri Shankara Cancer Hospital and Research Centre, Bangalore.
- Solid organ and blood cancers in adults and children
- Precision oncology
- Immunotherapy
- Preventive oncology
- Integrative oncology.
- Co-authored an original research paper – ‘Estimation of Vit B12 and Vit D levels in Type2 DM patients on Metformin.’ Published in IJSR Vol 4, Issue 2 February 2015.
- Won 1st place for best original research – “Chronic Mesenteric ischaemia in patients with Type 2 Diabetes mellitus” at All India physicians annual conference in January 2016 at Hyderabad, India.
- Won 3rd place for All India Oncology fellow s quiz on colorectal cancer – November 2017
- Co-authored a paper – “ Role of pre-operative CA 125 levels in predicting the DFS and OS in epithelial ovarian cancer”, published in IJRCOG, January 2018
- Certified with ECMO after clearing the ESMO exam in September 2019
- Co-authored a paper Chronic Mesenteric ischaemia in patients with Type 2 Diabetes mellitus published in November 2021 in IJSR vol 10, issue 11
- Certified with MRCP UK(SCE) September, 20222.
Workshops and Conferences Attended
- Attended and Successfully Completed BLS & ACLS Provider Course Certified by AHA – at St John's Medical College, Bangalore(AHA Appointed Institution) (April 2012)
- “CME on ECG at IGMI & RI in Puducherry, India – Karnataka Chapter, JSS Medical College, Mysore (July 2013)
- National Symposium in Cardiology & 36th Annual CME in Internal Medicine, Bangalore (January 2014)
- Workshop on mechanical ventilation by ISCCM, Mysore (July 2014)
- State-level post-graduate medicine update programme (August 2014)
- Workshop on Management of Thromboembolism (October 2014)
- CME on Respiratory Emergencies (December 2014)
- Update in Hepatogastroenterology (January 2015)
- AIIMS emergency Ultrasound workshop (February 2015)
- CME on Emergency medicine & trauma (February 2015)
- VIIIth World Congress on Clinical, Preventive Cardiology (March 2015)
- CME on clinical trials design and execution, Bangalore (November 2015)
- Update on breast cancer, Bangalore (March 2016)
- Lymphoma update (September 2016)
- Multiple myeloma symposium, Bangalore (February 2017)
- Renal cell Cancer update (September 2017)
- Colon cancer update (November 2017)
- Best of ASH update Bangalore (March 2018)
- MVR Cancon Kochi (October 2018)
- ESMO Academy(August, 2019).
Publications and Awards
- Co-authored an original research paper – ‘Estimation of Vit B12 and Vit D levels in Type2 DM patients on Metformin.’ Published in IJSR Vol 4, Issue 2 February 2015
- Won 1st place for best original research – “Chronic Mesenteric ischaemia in patients with Type 2 Diabetes mellitus” at All India physicians annual conference in January 2016 at Hyderabad, India
- Won 3rd place for All India Oncology fellow s quiz on colorectal cancer – November 2017
- Co-authored a paper – “ Role of pre-operative CA 125 levels in predicting the DFS and OS in epithelial ovarian cancer”, published in IJRCOG, January 2018
- Certified with ECMO after clearing the ESMO exam in September 2019
- Co-authored a paper Chronic Mesenteric ischaemia in patients with Type 2 Diabetes mellitus published in November 2021 in IJSR vol 10, issue 11
- Certified with MRCP UK(SCE) September 2022.
Research Interests
- Colorectal cancer and immunotherapy
- Haematolymphoid Malignancies
- Breast malignancies – Early detection and treatment in a resource-limited setting
- Pain and palliative care in oncology
- Depression management in terminal cancer patients.
Clinical Research Experience
Co-Investigator for the study titled “A Phase 3, Open-label, Randomised Study of Datopotamab Deruxtecan (Dato-DXd) Versus Investigator’s Choice of Chemotherapy in Patients who are not candidates for PD-1/PD-L1 Inhibitor Therapy in First-line Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast02)” Sponsored by Astrazeneca.